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ABSTRAK 
 
Sebahagian dari pesakit yang mengalami deman akut dengan trombositopenia, tidak 
semestinya mengidap penyakit denggi. Merawat mereka seperti mana mereka mengidap 
denggi adalah tidak wajar. Prevalens penyakit tersebut masih tidak diketahui. Objektif 
kajian ini adalah untuk menentukan prevalens penyakit deman akut dengan 
trombositopenia yang  bukan denggi di kalangan pesakit deman akut tidak spesifik dari 
klinik pesakit luar. Ini adalah satu kajian keratan rentas di klinik. Semua pesakit yang 
mengadu deman kurang dari dua minggu yang tidak spesifik dari Pusat Perubatan Primer 
Hospital Universiti Kebangsaan Malaysia (HUKM) dan Klinik kesihatan Batu 9 Hulu Langat 
dipilih untuk mengambil bahagian. Kajian kiraan darah lengkap (full blood count) pada hari 
pertama mereka ke klinik dan serologi denggi pada hari ke 5 selepas demam bermula 
dijalankan. Seramai 73 pesakit berjaya mengambil bahagian dari Mei hingga November 
2003. Di antara mereka, 47.9% (35) pesakit didapati mempunyai trombositopenia. Seramai 
40% (14) dari mereka yang mempunyai trombositopenia adalah negatif dalam ujian 
serologi denggi. Maka, pervalens penyakit deman akut dengan trombositopenia yang  
bukan denggi adalah 19.2%. Dengan ketaranya, sehagian pesakit di kalangan pesakit 
deman akut tidak spesifik, menunjukkan ujian serologi denggi negatif. Pesakit-pesakit ini 
harus dibezakan dari kalangan pesakit deman akut tidak spesifik, kerana mereka mungkin 
berbeza dari segi riwayat penyakit dan rawatanya.  
 
Kata kunci:  pesakit luar, penyakit demam akut, demam virus, trombositopenia, denggi. 
 
 
ABSTRACT 
 
A proportion of patients with acute viral fever with thrombocytopaenia does not necessary 
have dengue infection. Managing them indiscriminately as dengue infection may not be 
appropriate. The prevalence of this problem is not exactly known. The objective of this 
study is to determine the prevalence of acute non-dengue febrile thrombocytopaenia 
among adult patients presenting with acute non-specific febrile illness in an outpatient 
setting. This was a clinic-based cross sectional study. Consecutive patients presenting with 
non-specific febrile illness of less than two weeks were selected from the Primary Care 
Centre of Hospital Universiti Kebangsaan Malaysia (HUKM) and the Batu 9 Cheras Health 
Clinic. Full blood count was done on the day of visit and dengue serology was done on day 
five of illness for all patients enrolled. Seventy three patients participated in this study from 
May to November 2003. Among the patients, 35 (47.9%) were noted to have 
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thrombocytopaenia. Fourteen (40%) patients with thrombocytopaenia were serologically 
negative. The prevalence of non-dengue febrile thrombocytopaenia was 19.2%. A 
significant number of patients with acute non-specific febrile illness with 
thrombocytopaenia were negative for dengue serology. These patients should be 
differentiated from those with acute febrile thrombocytopaenia, as they might differ in their 
natural history from those with dengue infection, and hence require different management 
strategies. 
 
Keywords:  outpatient, acute febrile illness, viral fever, thrombocytopaenia, dengue. 
 
 
 
INTRODUCTION 
 
Non-specific viral febrile illness is a 
common encounter in an outpatient clinic 
(Teng et al. 2003). It is an important entity 
especially in countries where dengue 
infection is prevalent. This is because one 
of the common presenting symptoms of 
dengue infection is non-specific febrile 
illness (Gibbons and Vaughn 2002). Many 
clinicians would report and manage a case 
of acute non-specific viral febrile illness 
with thrombocytopaenia as dengue 
infection based on clinical assessment 
alone (Audit of Dengue notification in Pusat 
Perubatan Primer HUKM 2004). 
However, dengue infection is only one of 
the many causes of acute febrile 
thrombocytopaenia. Other causes of febrile 
thrombocytopaenia include scrub typhus, 
chikungunya fever, infectious mono-
nucleosis, malaria, typhoid fever, 
leptospirosis  and acute human immuno-
deficiency virus conversion disease 
(Vaughn and Green. 2000). Reporting 
every case of acute non-specific viral 
febrile thrombocytopaenia as dengue 
infection would lead to over reporting. 
Furthermore, managing all cases of acute 
non-specific viral febrile illness with 
thrombocytopaenia as dengue infection 
may not be appropriate as acute non-
dengue viral febrile illness with 
thrombocytopaenia may differ in their 
natural history and treatment from dengue 
infection. Some require less intensive 
monitoring as in chikungunya fever; some 
may need antibiotics such as scrub typhus 
and typhoid fever; some may have other 
serious outcome such as splenic rupture in 
infectious mononucleosis and acute human 
immunodeficiency virus conversion 
disease. Hence it is important to 
differentiate patients presenting to the 
outpatient setting with acute non-dengue 
febrile thrombocytopaenia from those 
having dengue infection. Deparis et al in 
1998 reported 15.5% of acute non-dengue 
febrile patients have thrombocytopaenia. 
There is no published data on the 
prevalence of such an entity among 
patients presenting with acute non-specific 
viral febrile illness. Knowing its prevalence 
will help us estimate the magnitude of the 
problem. The objective of this study was to 
determine the prevalence of non-dengue 
febrile thrombocytopaenia among febrile 
patients presenting to the outpatient clinic. 
 
MATERIALS AND METHOD 
 
This was a cross sectional study of a group 
of patients attending the Primary Care 
Center of Hospital Universiti Kebangsaan 
Malaysia (HUKM) and Batu 9 Health Clinic 
Hulu Langat, from May to November 2003. 
Consecutive patients who fulfilled the study 
criteria were invited to participate in the 
study. The inclusion criteria were age 12 
years and above with a history of fever of 
less than two weeks. Fever was defined as 
recorded oral temperature of more than 
37.5oC. Patients were excluded if there 
was an apparent localised source of 
infection e.g. urinary tract infection or acute 
abdomen. Any illness with pathognomonic 
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clinical features e.g. varicella infection, 
measles, rubella, scarlet fever and obvious 
features of dengue haemorrhagic 
manifestations were also excluded. 
Consents were taken from all eligible 
patients before enrolling them into the 
study. 
Full blood count examination was 
carried out for every patient seen. Patients 
were assumed to have dengue infection if 
thrombocytopaenia (platelet count of ≤ 
150X109/L) was detected. They were 
managed as per protocol for management 
of dengue infection. All the other patients 
with normal platelet count were called back 
on day 5 of illness for a repeat full blood 
count so as not to miss any possibility of 
thrombocytopaenia. Dengue serology was 
done for all patients on day five of illness, 
as early blood sampling of less then day 
five of illness might yield false negative 
results. If the patients require admission 
anytime during the study, the data was 
than collected from hospital records.  
Dengue serology tests were run with 
PanBio Rapid Immunochromatography 
method in the virology laboratory, HUKM. 
The methods, reagents used and 
interpretation of results were as described 
by the manufacturer. Primary acute dengue 
infection is defined as a positive serology 
test of IgM alone. Secondary infection is 
defined as a positive IgG with or without a 
positive IgM. Collectively, both primary and 
secondary infections constitute acute 
dengue infection. A negative result is when 
both IgG and IgM are negative.  
 
Statistical analysis and sample size 
calculation 
 
Analysis of the data was carried out using 
SPSS version 11. The denominator is the 
total number of cases presented as non-
specific febrile illness. Calculated minimal 
sample size of 61 patients was required, 
based on the estimated prevalence of non-
dengue thrombocytopaenia of 20% (95% 
confidence interval; worst estimated of 
10%) among patients presenting with acute 
non-specific viral febrile illness. Ethics 
approval was obtained from the research 
and ethics committee of the Medical 
Research Center UKM. 
 
RESULTS 
 
153 patients were screened, 49 did not 
give consent for the study and 17 were 
excluded for not fulfilling the criteria. 
Fourteen patients defaulted follow up as 
they claimed to be well and refused 
reassessment. Complete data was 
available for 73 patients. Mean age of the 
patients in this study was 27.3 years (27.3, 
SD±11.1). Their baseline characteristics 
are presented in table 1. Figure 1 
summarises the number of patients 
enrolled in this study. The majority of the 
patients enrolled were Malay (72.6%). 
 
 
Table 1: Baseline characteristics among 
patients presenting with non-specific febrile 
illness. 
 
Demographic characteristic n=73 
Mean age (± SD) in years  29.1(±12.9) 
Sex  Male  49 
 Female  24 
Race Malay  53 
 Chinese  9 
 Indian  7 
 Others   4 
 
 
Thirty five of 73 patients were found to 
have thrombocytopaenia. Hence, the 
prevalence of thrombocytopaenia among 
acute non-specific febrile illness was 
47.9%. Among these patients, 40% (14) 
were serologically negative for dengue 
infection, and only 60% (21) were 
diagnosed to have dengue infection. The 
overall prevalence of acute non-dengue 
viral thrombocytopaenia among patients 
presenting with non-specific viral fever is 
therefore 19.2%. 
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Patients screened for the 
study
153
No consent: 49
Excluded, not fulfilling 
criteria: 17
Patients included in the study: 87
Defaulted: 14
Patients who completed the study:
n=73
Patients with thrombocytopaenia: 
35
Patients without 
thrombocytopaenia: 38
D
Figure 1: Patients enrolled in the study. 
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Of the remaining 38 patients with the 
normal platelet count, three were tested 
positive for dengue serology. Therefore, 
total number of dengue infection was 24 
and hence the prevalence of dengue 
infection among patients presenting with 
non-specific viral fever was 32.9%.  
 
DISCUSSION 
 
This study confirmed that thrombo-
cytopaenia is common among adult 
patients with non-specific febrile illness. 
About half of them (47.9%) had 
thrombocytopaenia. A significant proportion 
of patients with thrombocytopaenia (40%) 
were serologically negative for dengue 
infection. Hence, equating all patients with 
thrombocytopaenia as having dengue 
infection may lead to over diagnosis. 
However, one has to be cautious when 
interpreting this data. Panbio Rapid 
Immunochromatography test kit was used 
as a gold standard for diagnosis in this 
study. Serologically negative result for 
dengue does not rule out dengue infection. 
Antigen detection by polymerase chain 
reaction, viral culture or paired serology 
should be used as the gold standard for 
diagnosis (WHO 1997). Therefore, even 
though Panbio Rapid Immunochromato-
graphy test kit has very good sensitivity 
and specificity, false positive and negative 
test results do occur. In reference to a local 
study by Lam et al., the false negative rate 
of this Panbio Rapid test was 0% 
(sensitivity of 100%) and the false positive 
rate was 11% (specificity of 89%) (Lam and 
Devine 1998). Whereas, Vaughn et al. 
demonstrated that 80% of dengue patients 
would show a diagnostic level of secondary 
dengue infection by day 1 of 
defervescence using haemagglunition-
inhibition test (HAI, in detecting IgG) which 
gave a false negative of 20%. Day of 
defervescence was defined as the day 
when the temperature dropped below 38oC 
which commonly occurs around day 5 to 7 
of illness (Vaughn et al. 1997). In the 
present study, the false negative rate for 
serological diagnosis using Panbio Rapid 
Immunochromatography test was probably 
less then 20%. Considering the rate of 
false negative as 20%, there would still be 
11 patients (33.3%) with seronegative 
results and the prevalence of acute non-
dengue viral thrombocytopaenia among 
patients presenting with non-specific viral 
fever would therefore be 15.1%. 
Deparis et al reported that 15.5% of 
acute non-dengue febrile patients have 
thrombocytopaenia (Deparis et al. 1998). 
However, patients from this study were 
among those suspected to have dengue 
infection, and not all patients with acute 
non-specific febrile illness were from an 
outpatient setting. From this data, it is 
evident that non-dengue thrombo-
cytopaenia is a significant entity that should 
be differentiated with dengue infection. It is 
important to differentiate between these 
two groups, as acute non-dengue febrile 
thrombocytopaenia might be different in 
their natural history from those with dengue 
infection. At present, all patients with acute 
non-specific febrile illness and thrombo-
cytopaenia are assumed to have dengue 
fever, and they are managed as such. This 
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may not be the appropriate management 
as the other causes of febrile thrombo-
cytopaenia require different management 
strategies.  
In this study, data were collected 
prospectively in order to standardise data 
collection and to minimise incomplete data. 
The patients selected were all from 
outpatient clinic with non-specific viral 
febrile illness and the result confirmed that 
dengue infection indeed is a common 
problem among them during the non-
epidemic season, whereby the prevalence 
was 32.9%. The prevalence of dengue 
infection is consistent with that of other 
studies, where dengue infection is 
endemic, ranging from 21%-35% (Trofa et 
al. 1997, Deparis et al. 1998, Akram et al. 
1998, Kalayanarooj et al. 1998). However, 
32.8% of the patients eligible for this study 
were unwilling to participate. They were 
probably suffering from a milder form of 
non-dengue viral fever. Hence, the true 
prevalence might be lower then 32.9%. 
During an epidemic episode, the 
prevalence might increase up to as high as 
90% (Teerakut et al. 1990). There is no 
published data on the prevalence of 
dengue infection among patients 
presenting with undifferentiated fever from 
Malaysia. Chin et. al. in 1993 reported 
69.4% and 85.7% of clinically diagnosed 
dengue fever and dengue haemorrhagic 
fever respectively were serologically 
positive. However, these were among 
patients with clinically diagnosed dengue 
infection and not all patients with 
undifferentiated fever (Chin et al. 1993). 
 
CONCLUSION 
 
Non-dengue febrile thrombocytopaenia is a 
significant entity among adult patients with 
acute non-specific febrile illness. 19.5% of 
these patients had non-dengue febrile 
thrombocytopaenia and 40% of 
thrombocytopaenic febrile patients were 
seronegative for dengue infection. It may 
not be appropriate to manage them as 
dengue infection because the course of the 
illness may differ significantly from dengue 
infection. A future study on this group of 
patients is needed in order to gain better 
understanding of its aetiological agents, 
natural history and hence guide us on the 
appropriate management.  
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